These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071 [TBL] [Abstract][Full Text] [Related]
9. Role of vincristine in the inhibition of angiogenesis in glioblastoma. Park KJ; Yu MO; Park DH; Park JY; Chung YG; Kang SH Neurol Res; 2016 Oct; 38(10):871-9. PubMed ID: 27472259 [TBL] [Abstract][Full Text] [Related]
10. Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. Proto MC; Gazzerro P; Di Croce L; Santoro A; Malfitano AM; Pisanti S; Laezza C; Bifulco M J Cell Physiol; 2012 Jan; 227(1):250-8. PubMed ID: 21412772 [TBL] [Abstract][Full Text] [Related]
11. Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Rong Y; Hu F; Huang R; Mackman N; Horowitz JM; Jensen RL; Durden DL; Van Meir EG; Brat DJ Cancer Res; 2006 Jul; 66(14):7067-74. PubMed ID: 16849552 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1) receptors: a keratinocyte-dependent effect. Magina S; Esteves-Pinto C; Moura E; Serrão MP; Moura D; Petrosino S; Di Marzo V; Vieira-Coelho MA Arch Dermatol Res; 2011 Apr; 303(3):201-10. PubMed ID: 21298280 [TBL] [Abstract][Full Text] [Related]
13. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Weissenberger J; Steinbach JP; Malin G; Spada S; Rülicke T; Aguzzi A Oncogene; 1997 May; 14(17):2005-13. PubMed ID: 9160879 [TBL] [Abstract][Full Text] [Related]
14. ETS-1 Expression Is Hypoxia-independent in Glioblastoma-derived Endothelial and Mesenchymal Stem-like Cells. Koessinger D; Albrecht V; Faber F; Jaehnert I; Schichor C Anticancer Res; 2018 Jun; 38(6):3347-3355. PubMed ID: 29848683 [TBL] [Abstract][Full Text] [Related]
15. Pharmacology of cannabinoid receptor agonists and a cyclooxygenase-2 inhibitor in rat bone tumor pain. Cui JH; Ju J; Yoon MH Pharmacology; 2013; 92(3-4):150-7. PubMed ID: 24008428 [TBL] [Abstract][Full Text] [Related]
16. Time- and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells. Said HM; Safari R; Al-Kafaji G; Ernestus RI; Löhr M; Katzer A; Flentje M; Hagemann C Oncol Rep; 2017 Jun; 37(6):3625-3634. PubMed ID: 28498432 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Normoxic and Hypoxic U-87 Glioblastoma Paracrine Secretion on the Modulation of Brain Endothelial Cells. Rado M; Flepisi B; Fisher D Cells; 2022 Jan; 11(2):. PubMed ID: 35053392 [TBL] [Abstract][Full Text] [Related]
18. CREBRF is a potent tumor suppressor of glioblastoma by blocking hypoxia-induced autophagy via the CREB3/ATG5 pathway. Xue H; Zhang J; Guo X; Wang J; Li J; Gao X; Guo X; Li T; Xu S; Zhang P; Liu Q; Li G Int J Oncol; 2016 Aug; 49(2):519-28. PubMed ID: 27278737 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. Iuvone T; Esposito G; De Filippis D; Bisogno T; Petrosino S; Scuderi C; Di Marzo V; Steardo L; J Mol Med (Berl); 2007 Dec; 85(12):1379-92. PubMed ID: 17639288 [TBL] [Abstract][Full Text] [Related]
20. Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans. Schley M; Ständer S; Kerner J; Vajkoczy P; Schüpfer G; Dusch M; Schmelz M; Konrad C Brain Res Bull; 2009 Jun; 79(5):333-7. PubMed ID: 19480992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]